Biden to Release More Doses: Virus Update
January 7th, 2021
News
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Inside The Two Biotech Companies Working Together On A Covid-19 Vaccine For Cats
January 6th, 2021
APDN to Participate in H.C. Wainwright BIOCONNECT 2021 Conference
January 5th, 2021
Applied DNA Announces Preliminary Estimated First Fiscal Quarter 2021 Revenues in the Range of $1.3 Million to $1.6 Million
January 4th, 2021
APDN, CLEARED4 Partner on COVID-19 Testing Program
December 29th, 2020
FY’20 Year End and Q4 Financial Results
December 17th, 2020
APDN Awarded Pooled Surveillance Testing Contract Valued at Up to $2M
December 17th, 2020
Counterfeit drugs: why on-dose authentication offers the most viable solution
December 15th, 2020
NY Winter COVID-19 Plan Drives Demand for Applied DNA’s Pooled Surveillance Testing Program
December 11th, 2020